Novel Pharmacotherapy for Hypertrophic Cardiomyopathy
Medical therapy for hypertrophic cardiomyopathy (HCM) has focused on minimizing the impact of symptoms due to left ventricular outflow tract obstruction and diastolic dysfunction. This article briefly discusses currently available therapy and focuses on both clinically available medications with novel applications for HCM as well as novel medications under development with specific indication for HCM. Finally, a brief summary of the current gaps and potential targets for pharmacotherapy is discussed.
Published In/Presented At
Wong, T. C., Martinez, M. w. (2018). Novel Pharmacotherapy for Hypertrophic Cardiomyopathy. Cardiology Clinics, 37(1), 113-117. DOI: /doi.org/10.1016/j.ccl.2018.08.008
Department of Medicine, Cardiology Division, Department of Medicine Faculty